Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Hayes

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Lipids in Health and Disease|August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2019
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage studyScott A McDonald, Stephen T Barclay, Sharon J Hutchinson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 21, 2012
Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosisKhalida A Lockman, James P Baren, Christopher J Pemberton, et al.
Lipids in Health and Disease|August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Journal of Viral Hepatitis|November 8, 2019
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosisScott A McDonald, Kevin G Pollock, Stephen T Barclay, et al.
Gut|March 2, 2020
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertensionDhiraj Tripathi, Adrian J Stanley, Peter C Hayes, et al.
Journal of Clinical Medicine|July 2, 2021
Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort StudyMohammad Inamul Haq, Thomas M Drake, Tee Lin Goh, et al.
Hepatology (Baltimore, Md.)|October 2, 2023
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysisOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
Obesity Science & Practice|October 11, 2021
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes StudySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
The Lancet. Gastroenterology & Hepatology|May 25, 2023
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S Bajaj, Ashok K Choudhury, Qing Xie, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Lipids in Health and Disease|August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2019
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage studyScott A McDonald, Stephen T Barclay, Sharon J Hutchinson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 21, 2012
Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosisKhalida A Lockman, James P Baren, Christopher J Pemberton, et al.
Lipids in Health and Disease|August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Journal of Viral Hepatitis|November 8, 2019
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosisScott A McDonald, Kevin G Pollock, Stephen T Barclay, et al.
Gut|March 2, 2020
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertensionDhiraj Tripathi, Adrian J Stanley, Peter C Hayes, et al.
Journal of Clinical Medicine|July 2, 2021
Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort StudyMohammad Inamul Haq, Thomas M Drake, Tee Lin Goh, et al.
Hepatology (Baltimore, Md.)|October 2, 2023
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysisOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
Obesity Science & Practice|October 11, 2021
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes StudySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
The Lancet. Gastroenterology & Hepatology|May 25, 2023
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S Bajaj, Ashok K Choudhury, Qing Xie, et al.
Pageof 17